| 000 | 01232 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513175208.0 | ||
| 264 | 0 | _c19990525 | |
| 008 | 199905s 0 0 eng d | ||
| 022 | _a0149-2918 | ||
| 024 | 7 |
_a10.1016/s0149-2918(00)88289-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZeldis, J B | |
| 245 | 0 | 0 |
_aS.T.E.P.S.: a comprehensive program for controlling and monitoring access to thalidomide. _h[electronic resource] |
| 260 |
_bClinical therapeutics _cFeb 1999 |
||
| 300 |
_a319-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aDermatologic Agents _xadverse effects |
| 650 | 0 | 4 | _aDrug Monitoring |
| 650 | 0 | 4 |
_aDrug and Narcotic Control _xorganization & administration |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 |
_aPregnancy Complications _xdrug therapy |
| 650 | 0 | 4 |
_aThalidomide _xadverse effects |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aWilliams, B A | |
| 700 | 1 | _aThomas, S D | |
| 700 | 1 | _aElsayed, M E | |
| 773 | 0 |
_tClinical therapeutics _gvol. 21 _gno. 2 _gp. 319-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0149-2918(00)88289-2 _zAvailable from publisher's website |
| 999 |
_c10170774 _d10170774 |
||